Reviews and PerspectivesReviews in Basic and Clinical Gastroenterology and HepatologyMechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
Section snippets
Biochemical Effects of Nonsteroidal Anti-Inflammatory Drugs
The biochemical actions common to all conventional NSAIDs are their topical effects, and inhibition of COX1 and COX2. These biochemical actions are brought about by the physicochemical properties that NSAIDs share,44, 45, 46 namely being lipid-soluble weak acids (see Figure 2). This combination provides them with detergent action (interaction with phospholipids), uncoupling of oxidative phosphorylation, and noncovalent inhibition of COX1 and COX2. These biochemical activities depend on the same
Inhibition of Cyclooxygenase 1 and 2 and Role of Prostaglandins
The 3-dimensional structure of the COX enzymes reveals the active site of both COX isoforms to be at the end of a hydrophobic channel. NSAIDs inhibit the enzyme by blocking the entrance of arachidonic acid to this channel and thereby denying substrate access to the active site.84, 85 The COX1 and 2 channels differ. Conventional NSAIDs have access to both channels and form an ionic bond via their carboxyl or enolic group.86 The COX1 channel is smaller than the channel in COX2 and does not
Tissue Reaction and Role of Luminal Aggressors
The tissue reaction is characterized by inflammation and the presence of erosions and ulcers, and this appears to be driven by COX inhibition and the luminal aggressive factors. The luminal aggressors differ between the stomach (acid, pepsin, and H pylori) and small bowel (bile and commensal bacteria). The importance of gastric luminal aggressors is widely appreciated, but the same does not hold true for small bowel aggressors. Our review focuses on effects in the small bowel.
Future Directions
Prevention and treatment of the adverse events of NSAIDs on the gastrointestinal tract require knowledge of mechanisms of pathogenesis of the lesions. The complexities of the pathways to this damage have been evident for a long time, but have not received much attention, presumably because the effects of inhibiting COX enzymes offer a simple and logical explanation for the damage. This hypothesis led to development of the COX2-selective agents with increased gastrointestinal safety. However,
Acknowledgments
Authors contributions: The study concept originated with IB. EH and MO wrote the first draft and carried out the literature search while IB supervised them and did most of the modifications before CS, KR, and AL contributed their expertise, as well as general comments. All authors contributed to the interpretation of data.
Writing assistance: Professor Brian Callingham, Department of Pharmacy, Queens College, University of Cambridge read and commented on the final version of the manuscript.
References (154)
- et al.
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine
Gastroenterology
(1993) Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents
Prostaglandins
(1981)Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and gastrointestinal damage induced by indomethacin in the rat
Gastroenterology
(1981)On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs
Biochem Biophys Acta
(1977)- et al.
Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study
Gastroenterology
(1989) - et al.
Gastric mucosal defense and cytoprotection: bench to bedside
Gastroenterology
(2008) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years
Gastroenterology
(1997)- et al.
The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal anti-inflammatory drugs and endothelin
Gastroenterology
(1990) - et al.
Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat
Gastroenterology
(2007) - et al.
Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate
Gastroenterology
(1992)
Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rat
Gastroenterology
Prostaglandin synthase 1 gene disruption in mice reduced arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
Cell
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
Gastroenterology
NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2
Gastroenterology
Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease
Clin Gastroenterol Hepatol
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Cell
Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study
Clin Gastroenterol Hepatol
An investigation into the role of mucus thickness on mucoadhesion in the gastrointestinal tract of pig
Eur J Pharm Sci
Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs
Gastroenterology
Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine
Biochem Biophys acta
Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats
Gastroenterology
Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects
Am J Gastroenterol
Tight junction dynamics: is paracellular transport regulated?
Cell
Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy
Am J Med
Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes
Biochem Pharmacol
The mechanism of inhibition of mitochondrial oxidative phosphorylation by the non-steroidal anti-inflammatory agent diflunisal
Biochem Pharmacol
Oxidative phosphorylation and respiration by rat liver mitochondria from aspirin treated rats
Biochem Pharmacol
Cyclooxygenase enzymes: catalysis and inhibition
Curr Opin Struct Biol
Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate
Free Radic Biol Med
Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study
Gastroenterology
Epidemiology of NSAID induced gastrointestinal complications
J Rheumatol
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
Lancet
Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis
N Engl J Med
Determinants of the short-term gastric damage caused by NSAIDs in man
Aliment Pharmacol Ther
Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions
J Rheumatol Suppl
A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy
Gastroenterology
Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs
Nature
Towards a better aspirin
Nature
Relation between ulcerogenic activity of various NSAID and their potency as inhibitors of prostaglandin synthesis in vivo
Agents Actions
Prevention of NSAID-induced gastric ulcer with misoprostol: multicenter double blind, placebo-controlled trial
Lancet
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatoy drugs
Ann Int Med
Cytoprotection by prostaglandins
Gastroenterology
The prevention and healing of acute NSAID-associated gastroduodenal mucosal damage by misoprostol
Br J Rheumatol
Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review
Clin Gastroenterol Hepatol
Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
Physiol Rev
Unwanted effects of aspirin and related agents on the gastrointestinal tract
Mechanism underlying gastric mucosal damage induced by indomethacin and bile salt, and the actions of prostaglandins
Br J Pharmacol
Protective mechanisms of the gastric mucosa
Vasoconstriction with thromboxane A2 induces ulceration of gastric mucosa
Nature
The 1994 Merk Frosst Award. Mechanism of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage-potential for development of gastrointestinal tract safe NSAIDs
Can J Physiol Pharmacol
Cited by (304)
A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage
2024, Cell Host and MicrobeEffects of Red ginseng on neuroinflammation in neurodegenerative diseases
2024, Journal of Ginseng ResearchProgress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management
2023, European Journal of Medicinal ChemistryApium extract alleviates indomethacin-induced gastric ulcers in rats via modulating the VEGF and IK-κB/NF-κB p65 signaling pathway: insights from in silico and in vivo investigations
2024, BMC Complementary Medicine and Therapies
Conflicts of interest Drs Bjarnason, Scarpignato, Rainsford, and Lanas have received lecture fees, travel support, research grants and sat on advisory panels of a number of pharmaceutical companies, some of which are involved with NSAIDs or drugs to prevent or heal their adverse effects on the intestinal tract. The remaining authors disclose no conflicts.